Browsing Category

Top Industry News

7231 posts

Packaging Companies Amcor, Berry Global To Merge in $8.4-Billion Deal 
By

By
Amcor, a Zurich, Switzerland-based provider of packaging for the pharmaceutical, food, beverage, and other markets, has agreed to acquire Berry Global, an Evansville, Indiana-based provider of packaging for various markets,…

Griflos Turns Down $6.8-Bn Takeover Offer 
By

By
Grifols, a Barcelona, Spain-headquarted healthcare company and manufacturer of plasma-derived medicines, has turned a potential offer of EUR 6.45 billion ($6.76 billion) by Brookfield, a Toronto, Canada-based private equity firm.  …

Novartis Acquires Gene-Therapy Company Kate Therapeutics in $1.1-Bn Deal
By

By
Novartis has acquired Kate Therapeutics, a San Diego, California-based gene-therapy company for treating genetically defined neuromuscular diseases, in a $1.1-billion deal (undisclosed upfront payment and additional milestone payments)  Kate Therapeutics’…

Supplier News: Samsung Biologic, Fujifilm Diosynth, Evotec & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Samsung Biologics, Fujifilm Diosynth Biotechnologies, Vetter, Pii, and Evotec.   Biologics Manufacturing * Samsung Biologics Signs $668-M Contract Mfg Deal* Fujifilm Diosynth Biotechnologies Completes…

Mfg News: Sanofi, Orano Med & Endo 
By

By
A roundup of manufacturing news from Sanofi, Orano Med, and Endo. Highlights below  * Sanofi Investing $42 M To Expand Bioproduction in France* Orano Med Investing $262 M To Expand…

Global Briefs: Pfizer, Amgen & Novartis 
By

By
A roundup of news from Pfizer, Amgen, and Novartis. Highlights below.   Appointments * Pfizer Names New Chief Scientific Officer & President, R&D * Amgen Names New Chief Scientific Officer, SVP of Research Partnering *…

AstraZeneca Investing $3.5 Bn in US-Based R&D & Mfg 
By

By
AstraZeneca has announced $3.5 billion of capital investment in the US focused on expanding the company’s research and manufacturing footprint by the end of 2026. This includes $2 billion of…

Merck & Co., LaNova In $3.3-Bn Licensing Pact 
By

By
Merck & Co. and LaNova Medicines, a Shanghai-based bio/pharmaceutical company, have entered into an exclusive global license to develop, manufacture and commercialize LaNova Medicine’s LM-299, an investigational bispecific antibody from…

Otsuka, ICU Medical In Joint Venture for IV Solutions Supply 
By

By
Otsuka Pharmaceutical Factory (OPF), a subsidiary of Otsuka Holdings, and ICU Medical, a medical device company, have formed a joint venture (JV) for IV solutions to serve the North American…

Supplier News: Lonza, Adragos, Avantor & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Lonza, Avantor, Adragos Pharma, Gilero, Sekisui Cryoport and GenScript Biotech.   Chemicals/Chemical API Manufacturing * Lonza To Expand Bioconjugation With Two New Mfg Suites Biologics…